Journal
CANCER RADIOTHERAPIE
Volume 23, Issue 2, Pages 147-150Publisher
ELSEVIER
DOI: 10.1016/j.canrad.2018.05.006
Keywords
Metastatic melanoma; Brain metastases; Stereotactic radiotherapy; Immune check point inhibitors; Anti-BRAF treatment
Ask authors/readers for more resources
Whereas immune checkpoint inhibitors of serine/threonine protein kinase B-raf therapy dramatically changed metastatic outcomes of patients with melanoma, they remain at high risk of brain extension. Additional local treatment can be offered in this situation such as surgery and or stereotactic radiotherapy. In this review article, we describe the different options with published data and their optimal timing. (C) 2019 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
